DE60308836D1 - Ophthalmische zubereitung mit ascomycin - Google Patents

Ophthalmische zubereitung mit ascomycin

Info

Publication number: DE60308836D1
Authority: DE; Germany
Prior art keywords: ascomycin; ophthalmic preparation; ophthalmic; preparation
Prior art date: 2002-03-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60308836T

Other languages

English (en)

Other versions

DE60308836T2 (de

Inventor

Saunier Maggy Babiole

Jean-Claude Bizec

Pik-Han Wong

Shau-Fong Yen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-04

Filing date

2003-03-03

Publication date

2006-11-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60308836(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-03 Application filed by Novartis AG filed Critical Novartis AG

2006-11-16 Application granted granted Critical

2006-11-16 Publication of DE60308836D1 publication Critical patent/DE60308836D1/de

2007-04-26 Publication of DE60308836T2 publication Critical patent/DE60308836T2/de

2023-03-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DE60308836T 2002-03-04 2003-03-03 Ophthalmische zubereitung mit ascomycin Expired - Lifetime DE60308836T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US36151502P	2002-03-04	2002-03-04
US361515P		2002-03-04
US40927502P	2002-09-09	2002-09-09
US409275P		2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en)	2002-03-04	2003-03-03	Ophthalmic composition comprising ascomycin

Publications (2)

Publication Number	Publication Date
DE60308836D1 true DE60308836D1 (de)	2006-11-16
DE60308836T2 DE60308836T2 (de)	2007-04-26

Family

ID=27791682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60308836T Expired - Lifetime DE60308836T2 (de)	2002-03-04	2003-03-03	Ophthalmische zubereitung mit ascomycin

Country Status (27)

Country	Link
US (4)	US20050220823A1 (de)
EP (1)	EP1482936B1 (de)
JP (1)	JP4740542B2 (de)
KR (1)	KR100992948B1 (de)
CN (1)	CN1297270C (de)
AR (1)	AR038628A1 (de)
AT (1)	ATE341326T1 (de)
AU (1)	AU2003218679B2 (de)
BR (1)	BR0308184A (de)
CA (1)	CA2477769C (de)
CO (1)	CO5611133A2 (de)
DE (1)	DE60308836T2 (de)
DK (1)	DK1482936T3 (de)
EC (1)	ECSP045277A (de)
EG (1)	EG24403A (de)
ES (1)	ES2274214T3 (de)
IL (2)	IL163657A0 (de)
MX (1)	MXPA04008571A (de)
MY (1)	MY137563A (de)
NO (1)	NO20044092L (de)
NZ (1)	NZ534690A (de)
PE (1)	PE20030828A1 (de)
PL (1)	PL210870B1 (de)
PT (1)	PT1482936E (de)
RU (1)	RU2322982C2 (de)
TW (1)	TW200305437A (de)
WO (1)	WO2003074054A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4463681B2 (ja)	2002-07-15	2010-05-19	アルコン，インコーポレイテッド	眼内使用のための非ポリマー親油性薬学的インプラント組成物
EP2319493A3 (de) *	2002-07-23	2011-07-27	Novartis AG	Ophthalmische Salbenzusammensetzung , einen Wirkstoff, eine Salbengrundlage und eine Löslichkeits-/Dispergierbarkeitsvermittler enthaltend
GB0307866D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
BRPI0705564B8 (pt) *	2007-10-10	2021-05-25	Embrapa Pesquisa Agropecuaria	sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (de)	2009-04-09	2010-10-13	Nestec S.A.	Getränkezubereitungsvorrichtung mit einem Verschlussmechanismus mit Mitteln zur starken Abnahme der Kraft
US8728516B2 (en) *	2009-04-30	2014-05-20	Abbvie Inc.	Stabilized lipid formulation of apoptosis promoter
EP2962688B1 (de) *	2009-05-12	2020-06-24	Galenica AB	Öl-in-wasser emulsion enthaltend mometason und propylenglycol
RU2550956C2 (ru) *	2009-12-22	2015-05-20	Эббви Инк.	Капсула авт-263
RU2437647C2 (ru) *	2010-02-27	2011-12-27	Пшеничников Виталий Георгиевич	Фармацевтическая композиция, обладающая антибактериальным, противовирусным и противогрибковым действием
EP2555748A2 (de) *	2010-04-07	2013-02-13	Allergan, Inc.	Konservierungsstoffkombinationen für ophthalmische zusammensetzungen
EP2664329A1 (de) *	2012-05-15	2013-11-20	F. Holzer GmbH	Ophthalmologisches Vehikelsystem
CN105431138B (zh) *	2013-03-27	2019-01-11	全球药物科技有限公司	眼药组合物、其制备方法及用途
WO2015080249A1 (ja) *	2013-11-29	2015-06-04	ロート製薬株式会社	眼科用又は耳鼻科用水性組成物
US20200237859A1 (en)	2019-01-25	2020-07-30	Newport Research, Inc.	Aqueous suspensions of cyclosporin
US11324800B2 (en)	2015-01-15	2022-05-10	Wellspring Ophthalmics, Inc.	Aqueous suspensions of cyclosporin
US10606760B2 (en) *	2017-08-23	2020-03-31	Samsung Electronics Co., Ltd.	Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (de) *	2019-05-21	2020-11-25	Premark Pharma GmbH	Behandlung von augenerkrankungen
TW202432089A (zh) *	2023-01-31	2024-08-16	溫士頓醫藥股份有限公司	一種滴眼油劑型的醫藥組合物
EP4687895A1 (de)	2023-04-06	2026-02-11	Premark Pharma GmbH	Verwendung von pimecrolimus zur behandlung des trockenen auges bei patienten mit einem hornhautfärbungswert von 4 oder 5 auf der oxford-abstufung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0406791B1 (de) *	1989-07-05	1995-02-01	Fujisawa Pharmaceutical Co., Ltd.	Wässriges flüssiges Mittel zur äusserlichen Anwendung
EP0474126B1 (de) *	1990-09-04	1997-03-19	Fujisawa Pharmaceutical Co., Ltd.	Tricyclische Verbindungen enthaltende Salben
PH31204A (en) *	1990-11-02	1998-05-05	Fujisawa Pharmaceutical Co	Pharmaceutical composition.
IE65341B1 (en) *	1990-11-08	1995-10-18	Fujisawa Pharmaceutical Co	Suspensions containing tricyclic compounds
WO1994005298A1 (en) *	1992-08-28	1994-03-17	Pharmos Corporation	Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) *	1993-06-08	1994-12-20	Fujisawa Pharmaceut Co Ltd	ローション剤
AU680539B2 (en) *	1993-08-18	1997-07-31	Alcon Laboratories, Inc.	Use of ergoline derivatives for the treatment of glaucoma
CA2201134A1 (en) *	1994-10-10	1996-04-18	Alfred Sallmann	Ophthalmic and aural compositions containing diclofenac potassium
DE69525957T2 (de) *	1994-10-26	2002-11-14	Novartis Ag	Verwendung eines ungesättigten Fettalkohols
EP0737471A3 (de) *	1995-04-10	2000-12-06	L'oreal	Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung
FR2732598B1 (fr) *	1995-04-10	1997-05-09	Oreal	Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US6096785A (en) *	1996-07-30	2000-08-01	Novartis Nutrition Ag	Amino acid compositions and use thereof in treating renal dysfunction
FR2755852B1 (fr) *	1996-11-15	1998-12-24	Oreal	Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
JP3732525B2 (ja) *	1998-04-27	2006-01-05	アステラス製薬株式会社	医薬組成物
GB9826656D0 (en) *	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
MXPA01010988A (es) *	1999-04-30	2004-04-21	Sucampo Ag	Uso de un compuesto macrolido para el tratamiento del ojo seco.

2003
- 2003-02-28 PE PE2003000198A patent/PE20030828A1/es not_active Application Discontinuation
- 2003-02-28 AR ARP030100667A patent/AR038628A1/es unknown
- 2003-03-02 EG EG2003030208A patent/EG24403A/xx active
- 2003-03-03 KR KR1020047013051A patent/KR100992948B1/ko not_active Expired - Fee Related
- 2003-03-03 JP JP2003572571A patent/JP4740542B2/ja not_active Expired - Fee Related
- 2003-03-03 DK DK03711914T patent/DK1482936T3/da active
- 2003-03-03 WO PCT/EP2003/002156 patent/WO2003074054A1/en not_active Ceased
- 2003-03-03 DE DE60308836T patent/DE60308836T2/de not_active Expired - Lifetime
- 2003-03-03 CA CA2477769A patent/CA2477769C/en not_active Expired - Fee Related
- 2003-03-03 BR BR0308184-2A patent/BR0308184A/pt not_active IP Right Cessation
- 2003-03-03 PL PL370917A patent/PL210870B1/pl not_active IP Right Cessation
- 2003-03-03 TW TW092104405A patent/TW200305437A/zh unknown
- 2003-03-03 AT AT03711914T patent/ATE341326T1/de active
- 2003-03-03 MX MXPA04008571A patent/MXPA04008571A/es active IP Right Grant
- 2003-03-03 PT PT03711914T patent/PT1482936E/pt unknown
- 2003-03-03 ES ES03711914T patent/ES2274214T3/es not_active Expired - Lifetime
- 2003-03-03 CN CNB038052105A patent/CN1297270C/zh not_active Expired - Fee Related
- 2003-03-03 US US10/506,233 patent/US20050220823A1/en not_active Abandoned
- 2003-03-03 NZ NZ534690A patent/NZ534690A/en not_active IP Right Cessation
- 2003-03-03 MY MYPI20030758A patent/MY137563A/en unknown
- 2003-03-03 RU RU2004129593/15A patent/RU2322982C2/ru not_active IP Right Cessation
- 2003-03-03 IL IL16365703A patent/IL163657A0/xx unknown
- 2003-03-03 EP EP03711914A patent/EP1482936B1/de not_active Expired - Lifetime
- 2003-03-03 AU AU2003218679A patent/AU2003218679B2/en not_active Ceased
2004
- 2004-08-19 IL IL163657A patent/IL163657A/en not_active IP Right Cessation
- 2004-09-03 EC EC2004005277A patent/ECSP045277A/es unknown
- 2004-09-16 CO CO04092300A patent/CO5611133A2/es not_active Application Discontinuation
- 2004-09-27 NO NO20044092A patent/NO20044092L/no not_active Application Discontinuation
2009
- 2009-12-15 US US12/638,313 patent/US20100113501A1/en not_active Abandoned
2011
- 2011-03-01 US US13/037,399 patent/US20110152307A1/en not_active Abandoned
- 2011-09-23 US US13/241,340 patent/US20120015971A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20100113501A1 (en)	2010-05-06
PL370917A1 (en)	2005-06-13
MXPA04008571A (es)	2004-12-06
CN1297270C (zh)	2007-01-31
ECSP045277A (es)	2004-10-26
DE60308836T2 (de)	2007-04-26
NO20044092L (no)	2004-09-27
DK1482936T3 (da)	2007-01-08
ATE341326T1 (de)	2006-10-15
PT1482936E (pt)	2007-01-31
US20120015971A1 (en)	2012-01-19
CO5611133A2 (es)	2006-02-28
CN1638769A (zh)	2005-07-13
KR100992948B1 (ko)	2010-11-08
IL163657A (en)	2009-11-18
US20110152307A1 (en)	2011-06-23
NZ534690A (en)	2007-06-29
IL163657A0 (en)	2005-12-18
PE20030828A1 (es)	2003-11-04
KR20040094718A (ko)	2004-11-10
AU2003218679A1 (en)	2003-09-16
AR038628A1 (es)	2005-01-19
CA2477769A1 (en)	2003-09-12
ES2274214T3 (es)	2007-05-16
JP2005529851A (ja)	2005-10-06
MY137563A (en)	2009-02-27
TW200305437A (en)	2003-11-01
EP1482936A1 (de)	2004-12-08
BR0308184A (pt)	2005-01-11
JP4740542B2 (ja)	2011-08-03
RU2004129593A (ru)	2005-09-10
RU2322982C2 (ru)	2008-04-27
EG24403A (en)	2009-04-29
CA2477769C (en)	2011-01-18
PL210870B1 (pl)	2012-03-30
WO2003074054A1 (en)	2003-09-12
EP1482936B1 (de)	2006-10-04
US20050220823A1 (en)	2005-10-06
AU2003218679B2 (en)	2007-04-05
HK1071301A1 (en)	2005-07-15

Publication	Publication Date	Title
DE60327864D1 (de)	2009-07-16	Ballondissektor mit kanüle
DE602004020183D1 (de)	2009-05-07	Schrittmacher mit av-intervall-optimierung
DE50311697D1 (de)	2009-08-20	Zwischenwirbelimplantat mit kalottenartigen gelenkflächen
DE60319848D1 (de)	2008-04-30	Medikament mit mesenchym-stammzellen
ATE341326T1 (de)	2006-10-15	Ophthalmische zubereitung mit ascomycin
DE602004002987D1 (de)	2006-12-14	Linseneinführsystem
IS8043A (is)	2005-09-23	Gervigras
DE60311076D1 (de)	2007-02-22	Nanostrukturen mit pilin-protein
DE50311234D1 (de)	2009-04-09	Zwischenwirbelimplantat mit temporären blockiermitteln
DE60308332D1 (de)	2006-10-26	Chinazolinverbindungen mit therapeutischem nutzen
DE60234840D1 (de)	2010-02-04	Ascomycin enthaltende ophthalmische zubereitungen
ATE472576T1 (de)	2010-07-15	Polyalkenamine mit verbesserten anwendungseigenschaften
DE602004006816D1 (de)	2007-07-19	Ladegerät
EP1494530A4 (de)	2009-06-24	Kombinationstherapie mit kleepeptiden
DE50308343D1 (de)	2007-11-22	Armlehne
DE60238111D1 (de)	2010-12-09	Viszeralfettmesser mit tonometer
DE602004014252D1 (de)	2008-07-17	Avermectinmonosaccharidderivate mit pestiziden eigenschaften
DE60322421D1 (de)	2008-09-04	Verbesserter brillenbügel
SE0300137L (sv)	2004-07-21	Infusionssats
DE60328921D1 (de)	2009-10-01	Kondom mit integriertem wulstaufbau
DE602004032351D1 (de)	2011-06-01	Kulierstrick- oder kulierwirkmaschine mit bewegbarer platine
DE60311138D1 (de)	2007-02-22	Pll mit symmetrischem quadrikorrelator
DE602004000838D1 (de)	2006-06-14	Intraokularlinse
DE602004024223D1 (de)	2009-12-31	Drehscheibe mit positionseinstellung
DE50309332D1 (de)	2008-04-17	Empfangsanordnung mit vorverstärkerschaltung

Legal Events

Date	Code	Title	Description
2007-11-15	8364	No opposition during term of opposition
2010-05-20	8328	Change in the person/name/address of the agent	Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336
2011-06-16	8328	Change in the person/name/address of the agent	Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN